CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 72  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0599
LYS 10.0233
GLU 20.0212
LEU 30.0288
ARG 40.0424
CYS 50.0214
GLN 60.0033
CYS 70.0233
ILE 80.0225
LYS 90.0067
THR 100.0063
TYR 110.0085
SER 120.0369
LYS 130.0562
PRO 140.0240
PHE 150.0119
HIS 160.0191
PRO 170.0089
LYS 180.0314
PHE 190.0247
ILE 200.0139
LYS 210.0417
GLU 220.0363
LEU 230.0185
ARG 240.0242
VAL 250.0187
ILE 260.0077
GLU 270.0087
SER 280.0079
GLY 290.0397
PRO 300.0532
HIS 310.0113
CYS 320.0106
ALA 330.0124
ASN 340.0095
THR 350.0116
GLU 360.0109
ILE 370.0081
ILE 380.0149
VAL 390.0037
LYS 400.0086
LEU 410.0146
SER 420.0215
ASP 430.0259
GLY 440.0313
ARG 450.0212
GLU 460.0159
LEU 470.0172
CYS 480.0104
LEU 490.0043
ASP 500.0145
PRO 510.0111
LYS 520.0096
GLU 530.0255
ASN 540.0315
TRP 550.0227
VAL 560.0165
GLN 570.0150
ARG 580.0179
VAL 590.0127
VAL 600.0042
GLU 610.0107
LYS 620.0141
PHE 630.0076
LEU 640.0265
LYS 650.0573
ARG 660.0273
ALA 670.0453
GLU 680.0599
ASN 690.0472

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.